96 investors have funded 25 Life Sciences companies head-officed in Princeton, across 129 rounds (Jun 1996 – Jun 2025). They are ranked by how many Princeton companies in this market they have actually backed.
"In Princeton" describes the companies, not the investor: most of the money in any city comes from somewhere else, and the Where the money comes from section below shows exactly where it came from here.
Ranked by companies backed in this market and city, then by round count. "Led" counts rounds recorded with this investor as lead.
| # | Investor | Based in | Stages here | Companies | Rounds | Led | Latest | Portfolio total |
|---|---|---|---|---|---|---|---|---|
| 1 | TL Ventures | Wayne, United States | Series CSeries BSeries A | 2 | 4 | 2 | Sep 2004 | 54 |
| 2 | New Enterprise Associates | Menlo Park, United States | Series BSeries A | 2 | 3 | 2 | Feb 2019 | 1,110 |
| 3 | ProQuest Investments | Princeton, United States | Series BSeries CSeries A | 2 | 3 | 1 | Jul 2012 | 35 |
| 4 | MPM Capital | Boston | Series CSeries B | 2 | 2 | 1 | Aug 2004 | 127 |
| 5 | Bay City Capital | San Francisco, United States | PESeries A | 2 | 2 | — | Jan 2018 | 60 |
| 6 | Kalaari Capital | Bengaluru, India | Series BSeries DSeries C | 1 | 4 | — | Jan 2019 | 154 |
| 7 | Aarin Capital | Bengaluru, India | Series BSeries CSeries A | 1 | 3 | — | Jul 2016 | 36 |
| 8 | Navam Capital | Kolkata, India | Series BSeries ASeed | 1 | 3 | 1 | Aug 2014 | 21 |
| 9 | Insight Partners | New York City, United States | Seed | 1 | 2 | 1 | Jun 2025 | 762 |
| 10 | J P Morgan | New York City, United States | Series CSeries B | 1 | 2 | — | Oct 2003 | 293 |
| 11 | Versant Ventures | Basel, Switzerland | Series ASeries B | 1 | 2 | 1 | Feb 2019 | 174 |
| 12 | Sofinnova Partners | Paris, France | Series ASeries B | 1 | 2 | 1 | Jan 2012 | 149 |
| 13 | Perceptive Advisors | New York City, United States | Series DSeries C | 1 | 2 | 1 | Jan 2019 | 172 |
| 14 | Credit Suisse | Zurich, Switzerland | Series ASeries B | 1 | 2 | — | Sep 2004 | 151 |
| 15 | Kaiser Permanente Ventures | Oakland, United States | Series BSeries C | 1 | 2 | 1 | Jul 2012 | 67 |
| 16 | Boehringer Ingelheim Venture Fund | Ingelheim am Rhein, Germany | Seed | 1 | 2 | 2 | Jun 2025 | 54 |
| 17 | Sectoral | Montreal, Canada | Post-IPO | 1 | 2 | 1 | Aug 2015 | 42 |
| 18 | Romulus Capital | Boston, United States | Series CSeries D | 1 | 2 | 1 | Jan 2019 | 29 |
| 19 | Sabre Partners India | Mumbai, India | Series BSeries C | 1 | 2 | 1 | Jul 2016 | 21 |
| 20 | Advantech Capital | Hong Kong, China | Series A | 1 | 2 | 1 | Jan 2018 | 26 |
| 21 | Care Capital | Princeton, United States | Series BSeries C | 1 | 2 | 1 | Jul 2012 | 22 |
| 22 | Novitas Capital | Wayne, United States | Series BSeries C | 1 | 2 | 1 | Jul 2012 | 15 |
| 23 | Accelerator Life Science Partners | Seattle, United States | Series A | 1 | 2 | 2 | Jul 2023 | 14 |
| 24 | KBC Group | Brussels | Series CSeries B | 1 | 2 | — | Oct 2003 | 12 |
| 25 | Nor’easter Ventures | Cambridge, United States | Seed | 1 | 2 | — | Jun 2025 | 5 |
| 26 | Canaan | San Francisco, United States | Series A | 1 | 1 | — | Mar 2003 | 379 |
| 27 | Novo Holdings | Hellerup, Denmark | Seed | 1 | 1 | — | Dec 2019 | 286 |
| 28 | Founder Collective | Cambridge, United States | Seed | 1 | 1 | — | Mar 2019 | 336 |
| 29 | T. Rowe Price | Baltimore, United States | Post-IPO | 1 | 1 | 1 | Feb 2015 | 214 |
| 30 | Connecticut Innovations | New Haven, United States | Series A | 1 | 1 | — | Mar 2003 | 203 |
| 31 | IndieBio | San Francisco, United States | Seed | 1 | 1 | 1 | Oct 2021 | 252 |
| 32 | Invus | New York City, United States | Series B | 1 | 1 | 1 | Feb 2019 | 174 |
| 33 | Mubadala | Abu Dhabi, United Arab Emirates | Post-IPO | 1 | 1 | — | Jul 2021 | 167 |
| 34 | Cowin Capital | Shenzhen, China | Series A | 1 | 1 | — | Jan 2018 | 184 |
| 35 | NextView Ventures | Boston, United States | Seed | 1 | 1 | 1 | Mar 2019 | 128 |
| 36 | Johnson & Johnson Innovation – JJDC | New Brunswick, United States | Series C | 1 | 1 | — | Oct 2003 | 120 |
| 37 | Intersouth Partners | Durham, United States | Series A | 1 | 1 | — | Mar 2003 | 71 |
| 38 | NewSpring | Radnor, United States | Series A | 1 | 1 | — | Mar 2003 | 129 |
| 39 | Johnson & Johnson Innovation | New Brunswick, United States | Series A | 1 | 1 | — | Mar 2003 | 102 |
| 40 | Aisling Capital | New York City, United States | Series C | 1 | 1 | 1 | Jul 2012 | 78 |
| 41 | Pontifax | Herzliya, Israel | Post-IPO | 1 | 1 | 1 | Dec 2020 | 74 |
| 42 | Healthcap | Stockholm, Sweden | Series A | 1 | 1 | — | Mar 2003 | 68 |
| 43 | Adage Capital Management | Boston, United States | Post-IPO | 1 | 1 | 1 | Feb 2015 | 87 |
| 44 | Investor Growth Capital | New York City, United States | Series B | 1 | 1 | 1 | Jun 2010 | 78 |
| 45 | SDIC | Beijing, China | Series A | 1 | 1 | 1 | Jan 2018 | 91 |
| 46 | Ping An Ventures | Pudong, China | Series A | 1 | 1 | — | Jan 2018 | 74 |
| 47 | Burrill and Company | Wuxi, China | Series B | 1 | 1 | 1 | Aug 2004 | 57 |
| 48 | BioAdvance | Radnor, United States | Series A | 1 | 1 | — | Mar 2022 | 55 |
| 49 | Roche | Basel, Switzerland | Series B | 1 | 1 | 1 | Oct 2004 | 47 |
| 50 | Vida Ventures | Boston, United States | Series B | 1 | 1 | — | Feb 2019 | 45 |
| 51 | Hg | London, United Kingdom | Unattributed | 1 | 1 | — | Jun 1996 | 63 |
| 52 | MSD Capital | New York City, United States | Series B | 1 | 1 | 1 | Aug 2004 | 44 |
| 53 | Investor | Stockholm, Sweden | Series C | 1 | 1 | — | Jul 2012 | 40 |
| 54 | Iron Pillar | Ebene City, Mauritius | Series D | 1 | 1 | 1 | Jan 2019 | 22 |
| 55 | Korea Investment Partners | Singapore, Singapore | Series A | 1 | 1 | — | Jan 2018 | 33 |
| 56 | Lifeforce Capital | San Francisco, United States | Seed | 1 | 1 | 1 | Nov 2020 | 29 |
| 57 | Efung Capital | Shenzhen, China | Series A | 1 | 1 | — | Jan 2018 | 34 |
| 58 | REMUS | Boston, United States | Series D | 1 | 1 | — | Jan 2019 | 18 |
| 59 | IndoUS Venture Partners | Santa Clara, United States | Series A | 1 | 1 | 1 | Sep 2012 | 19 |
| 60 | Fitz Gate Ventures | Princeton, United States | Seed | 1 | 1 | — | Mar 2019 | 19 |
| 61 | Lincoln Park Capital | Chicago, United States | Post-IPO | 1 | 1 | — | Aug 2020 | 23 |
| 62 | Viva BioInnovator | Shanghai, China | Seed | 1 | 1 | — | Mar 2022 | 19 |
| 63 | Innospark | Boston, United States | Seed | 1 | 1 | — | Jun 2025 | 19 |
| 64 | Sangel Capital | Shenzhen, China | Series A | 1 | 1 | — | Jan 2018 | 17 |
| 65 | TVM Capital Life Science | Munich | Series A | 1 | 1 | 1 | Jun 2001 | 16 |
| 66 | Innospark Ventures | Boston | Seed | 1 | 1 | 1 | Mar 2022 | 17 |
| 67 | Broadfin Capital | New York City, United States | Post-IPO | 1 | 1 | 1 | Feb 2015 | 14 |
| 68 | TVM | Munich, Germany | Series B | 1 | 1 | 1 | Aug 2004 | 12 |
| 69 | Montagu | Frankfurt, Germany | Unattributed | 1 | 1 | — | Jun 1996 | 13 |
| 70 | Third Security | Radford, United States | Post-IPO | 1 | 1 | — | Jun 2013 | 7 |
| 71 | New Jersey Economic Development Authority | Newark | Seed | 1 | 1 | — | Apr 2009 | 11 |
| 72 | Flying L Partners | Newport Beach, United States | Series B | 1 | 1 | 1 | Feb 2019 | 10 |
| 73 | Foundation Venture Capital Group | Princeton, United States | Seed | 1 | 1 | — | Mar 2007 | 8 |
| 74 | Ventura Biomed | Germany | Series A | 1 | 1 | — | Oct 2023 | 7 |
| 75 | Iroquois Capital Group | Nashville, United States | Post-IPO | 1 | 1 | 1 | Jul 2010 | 8 |
| 76 | Knight Therapeutics | Westmount, Canada | Post-IPO | 1 | 1 | 1 | Aug 2015 | 5 |
| 77 | PTX Capital | Baltimore, United States | Seed | 1 | 1 | — | Mar 2022 | 5 |
| 78 | DAFNA Capital Management | Los Angeles, United States | Post-IPO | 1 | 1 | 1 | Jul 2010 | 6 |
| 79 | Keiretsu Forum Mid-Atlantic | Philadelphia, United States | Series A | 1 | 1 | 1 | Aug 2022 | 4 |
| 80 | Seaflower Ventures | Waltham, United States | Series A | 1 | 1 | — | Mar 2003 | 3 |
| 81 | Abbhi Capital | Coral Gables, United States | Unattributed | 1 | 1 | — | Jan 2017 | 3 |
| 82 | GF XINDE | Guangzhou, China | Series A | 1 | 1 | — | Jan 2018 | 2 |
| 83 | Elite Capital | Beijing, China | Series A | 1 | 1 | — | Jan 2018 | 2 |
| 84 | Rosland Capital | Los Angeles, United States | Post-IPO | 1 | 1 | 1 | Jul 2010 | 2 |
| 85 | Opus Point Partners | New York City, United States | Post-IPO | 1 | 1 | 1 | Jul 2010 | 2 |
| 86 | New Jersey Health Foundation | Princeton, United States | Seed | 1 | 1 | 1 | Mar 2018 | 2 |
| 87 | Rockmore Capital | West Palm Beach, United States | Post-IPO | 1 | 1 | 1 | Jul 2010 | 2 |
| 88 | Zoticon | Rehovot, Israel | Series C | 1 | 1 | 1 | Feb 2009 | 1 |
| 89 | Brio Capital Management | Rockville Centre, United States | Post-IPO | 1 | 1 | 1 | Jul 2010 | 1 |
| 90 | Sigma-Tau Pharmaceuticals | Gaithersburg, United States | Post-IPO | 1 | 1 | 1 | Jul 2010 | 1 |
| 91 | 7G BioVentures | Series A | 1 | 1 | — | Mar 2022 | 1 | |
| 92 | Arimedcapital.com | Seed | 1 | 1 | — | Mar 2022 | 1 | |
| 93 | Ab Magnitude Ventures Group | Morristown | Seed | 1 | 1 | — | Jun 2025 | 1 |
| 94 | RCTC | Camden, United States | Seed | 1 | 1 | — | Apr 2009 | 1 |
| 95 | Jiangsu Hengrui Medicine | Lianyungang, China | Series A | 1 | 1 | — | Jun 2016 | 1 |
| 96 | Shanghai Fudan Zhangjiang Bio-Pharmaceutical Co | Pudong, China | Series A | 1 | 1 | — | Feb 2017 | 1 |
Head office of the investors on this page.
Rounds by stage — where in a company's life this money arrives.
Total disclosed size of each round, not one investor's share.
How active this market has been.
Life Sciences companies head-officed in Princeton that took money from these investors.
| Company | Backers | Rounds | Disclosed | Latest round |
|---|---|---|---|---|
| Sopherion Therapeutics sopherion.com |
11 | 13 | $409M | Series C Feb 2009 |
| KBP BioSciences kbpbio.com |
10 | 11 | $836M | Series A Jan 2018 |
| Vyome Therapeutics vyometx.com |
9 | 19 | $226.4M | Series D Jan 2019 |
| ArrePath arrepath.com |
9 | 12 | $140M | Seed Jun 2025 |
| Soligenix soligenix.com |
9 | 9 | $68.4M | Post-IPO Dec 2020 |
| Agile Therapeutics agiletherapeutics.com |
7 | 11 | $465M | Series C Jul 2012 |
| Pharmasset pharmasset.com |
6 | 6 | $164M | Series B Oct 2004 |
| Advaxis advaxis.com |
6 | 7 | $142M | Post-IPO Aug 2020 |
| Oyster Point Pharmaceuticals oysterpointrx.com |
5 | 7 | $522.2M | Series B Feb 2019 |
| Barrier Therapeutics barriertherapeutics.com |
5 | 8 | $298M | Series C Oct 2003 |
| Kayothera kayothera.com |
4 | 5 | $29.2M | Series A Jul 2023 |
| Cheers cheershealth.com |
3 | 3 | $6.3M | Seed Mar 2019 |
| Omthera Pharmaceuticals omthera.com |
2 | 3 | $84.5M | Series B Jan 2012 |
| iQure Pharma iqurepharma.com |
2 | 2 | $2.1M | Series A Oct 2023 |
| ClinPhone clinphone.com |
2 | 2 | — | Unattributed Jun 1996 |
| Biopticon biopticon.com |
2 | 2 | — | Seed Apr 2009 |
| Certara certara.com |
1 | 1 | $250M | Post-IPO Jul 2021 |
| Hengrui Therapeutics hengruitx.com |
1 | 1 | $100M | Series A Jun 2016 |
| Adgero Biopharma adgerobiopharm.com |
1 | 1 | $2M | Series A Feb 2017 |
| Nanocan nanocan.life |
1 | 1 | $1.4M | Seed Nov 2020 |
| Snowdon snowdonpharma.com |
1 | 1 | $500K | Seed Mar 2007 |
| RizLab Health rizlabhealth.com |
1 | 1 | $250K | Seed Oct 2021 |
| ArisGlobal arisglobal.com |
1 | 1 | — | Unattributed Jan 2017 |
| Medarex medarex.com |
1 | 1 | — | PE Aug 1998 |
| Wcg Clinical wcgclinical.com |
1 | 1 | — | Seed Dec 2019 |
| Date | Investor | Company | Stage | Round size |
|---|---|---|---|---|
| Jun 2025 | Insight Partners | ArrePath | Seed | — |
| Jun 2025 | Boehringer Ingelheim Venture FundLED | ArrePath | Seed | — |
| Jun 2025 | Ab Magnitude Ventures Group | ArrePath | Seed | — |
| Jun 2025 | Nor’easter Ventures | ArrePath | Seed | — |
| Jun 2025 | Innospark | ArrePath | Seed | — |
| Oct 2023 | Ventura Biomed | iQure Pharma | Series A | $1.5M |
| Jul 2023 | Accelerator Life Science PartnersLED | Kayothera | Series A | $5.2M |
| Aug 2022 | Keiretsu Forum Mid-AtlanticLED | iQure Pharma | Series A | $600K |
| Mar 2022 | Accelerator Life Science PartnersLED | Kayothera | Series A | $8M |
| Mar 2022 | BioAdvance | Kayothera | Series A | $8M |
| Mar 2022 | 7G BioVentures | Kayothera | Series A | $8M |
| Mar 2022 | Insight PartnersLED | ArrePath | Seed | $20M |
| Mar 2022 | Boehringer Ingelheim Venture FundLED | ArrePath | Seed | $20M |
| Mar 2022 | Arimedcapital.com | ArrePath | Seed | $20M |
| Mar 2022 | Innospark VenturesLED | ArrePath | Seed | $20M |
| Mar 2022 | PTX Capital | ArrePath | Seed | $20M |
| Mar 2022 | Viva BioInnovator | ArrePath | Seed | $20M |
| Mar 2022 | Nor’easter Ventures | ArrePath | Seed | $20M |
| Oct 2021 | IndieBioLED | RizLab Health | Seed | $250K |
| Jul 2021 | Mubadala | Certara | Post-IPO | $250M |
Life Sciences investors in other cities
Other markets in Princeton